21Nov/13

UK's first gene therapy trial for patients with chronic heart failure begins … – News-Medical.net


Science Codex

UK’s first gene therapy trial for patients with chronic heart failure begins
News-Medical.net
The UK’s first gene therapy trial for advanced heart failure, CUPID 2, has officially begun at the Golden Jubilee National Hospital (GJNH); with the first candidate recently being administered with a dose of the MYDICAR treatment. The GJNH, home of the 
Study: Genes delivered directly to heart stymie heart failureFierceDrugDelivery
31 months of Gene Therapy Benefits Advanced Heart Failure PatientsNext Big Future
Long-lasting gene therapy benefits advanced heart failure patientsMedical Xpress

all 12 news articles »

21Nov/13

Alexa's Hope Attempts to Break Guinness Record Saturday – NDSU The Spectrum


The Concordian

Alexa’s Hope Attempts to Break Guinness Record Saturday
NDSU The Spectrum
Residents around the Fargo-Moorhead area have the opportunity not only to break a world record this Saturday, but also to help put a dent in previous numbers by signing up to be an organ donor. Alexa’s Hope, a The record is currently 4,135 donors
Students attempt to break record for registered organ donorsThe Concordian

all 3 news articles »

20Nov/13

Innovations and Developments of Rituximab Biosimilar Market – PR-BG.com (прессъобщения) (press release)

Innovations and Developments of Rituximab Biosimilar Market
PR-BG.com (прессъобщения) (press release)
November 21,2013 : Bharat Book Bureau presents the new report, on ‘Therapy Class Overview : Rituximab biosimilar’ assesses that Approval of Inflectra/Remsima, the first biosimilar Monoclonal antibody (Mab) from Celltrion and Hospira in EU in 2013 is a